Abstract
There are little long-term clinical data regarding the safety and efficacy of using 2 drug-eluting stents (DESs) to treat coronary bifurcation lesions. We obtained clinical follow-up for 124 consecutive patients who underwent bifurcation stenting with 2 DESs. Major adverse cardiac events (MACEs) were defined as cardiac death, acute myocardial infarction (AMI), and target vessel revascularization (TVR). Sixty-four (52%) patients underwent "crush," 42 (34%) patients underwent T stent, and 18 (14%) patients underwent kissing stent. Major adverse cardiac events were observed in 19 patients (17%) at 1 year: 6 (5%) AMI, 13 (12%) TVR, and no deaths, and 29 patients (26 %) at a mean follow-up of 22 months: 7 (6%) AMI, 21 (19%) TVR, and 1 (1%) death. No statistically significant risk factors for long-term MACEs were identified. It appears that treating bifurcation lesions with 2 DESs when necessary can be performed with an acceptable MACE rate.
| Original language | English |
|---|---|
| Pages (from-to) | 633-637 |
| Number of pages | 5 |
| Journal | Angiology |
| Volume | 61 |
| Issue number | 7 |
| DOIs | |
| State | Published - Oct 2010 |
| Externally published | Yes |
Keywords
- bifurcation
- complex intervention
- drug-eluting stent
Fingerprint
Dive into the research topics of 'Long-term outcome of bifurcation stenting with drug-eluting stents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver